16 out. FARMACOLOGIA CARDIOVASCULAR GRUPO 5. CASO CLÍNICO EXAME FÍSICO No momento da consulta, o exame físico não apresentava. Thank You! Farmacos Antianginosos e hipotensores. Una de las patologías y molestias mas frecuentes de la cardiopatía isquemica. MEDICAMENTOS CARDIOVASCULARES. Antianginosos. ATENOLOL. Comprimido 50 mg. (; ). Comprimido mg.

Author: Kagacage Dougrel
Country: Slovenia
Language: English (Spanish)
Genre: Automotive
Published (Last): 17 November 2006
Pages: 56
PDF File Size: 17.51 Mb
ePub File Size: 2.1 Mb
ISBN: 161-7-89601-167-8
Downloads: 20378
Price: Free* [*Free Regsitration Required]
Uploader: Gazuru

Comedications most frequently prescribed were: Similares no Google Citados no Google Scholar. Acceso el 10 febrero Cholesterol control, medication adherence and illness cognition. Dyslipidemia is a primary risk factor for developing coronary heart disease and stroke, frequent causes of morbidity and mortality in Colombia and the world. Am J Manag Care.


Update for primary healthcare providers: Estas investigaciones contribuyen al uso racional de medicamentos. Antianginals and ASA were being underused, while anianginosos and antiulcer drugs were being overused. Prescriptions were ranked as follows: Dyslipidemia; hyperlipidemia; hypertriglyceridemia; drug therapy, lipid; drugs with prescription; Colombia.

ReadCube Visualizar o texto. Factores de riesgo para enfermedades cardiovasculares.

Nitroglicerina (fármaco)

Effective use of combination lipid therapy. The mean age was Cardiovascular disease and lipids.

Prescription patterns for antilipidemic drugs in a group of Colombian patients. The use of a hospital laboratory cohort to estimate the prevalence of dyslipidemia in an adult Bra zilian population. Differences between clinical trial efficacy and real-world effectiveness.


Arterioscler Thromb Vasc Biol. Int J Clin Pract ; Existe subempleo de antianginosos y ASA y sobreempleo de antiinflamatorios y antiulcerosos. Vigilancia de los factores de riesgo para enfermedades no transmisibles: Lipid concentrations and the use of lipid lowering drugs: Clearly there is a need for creating educational strategies to address these prescribing habits and for exploring clinical results of the pharmaceuticals studied. Issues and evidence for the management of dyslipidaemia in primary care.

La dislipidemia es un factor de riesgo primario para desarrollar enfermedad coronaria y accidentes cerebrovasculares, causas frecuentes de morbilidad y mortalidad en Colombia y el mundo. Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men. A descriptive, observational study was conducted of 41 hyperlipidemics of both sexes, who were over 20 years of age, undergoing treatment from at least April to Juneand were residents of one of 19 cities in Colombia.

Br J Health Psychol.

Primatesta P, Poulter RN. All of the antilipidemics are being used at lower-than-recommended dosage levels. Patrones de uso de antihipertensivos en 11 pacientes darmacos. Acuerdo de A database was created to track prescription data collected by the pharmaceutical company that dispenses medications to the patients. Sanal S, Aronow WS. Strategies for optimizing treatment outcomes.


carmacos J Manag Care Pharm. Effect of an educational program on the prevalence of use of anti platelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.

Manuscrito recibido el 19 de enero de Recommendations for the management of dyslipidemia and prevention of cardiovascular disease: Asimismo, disponen de bases de datos pertinentes y confiables.

Las diferencias halladas entre los pacientes tratados con monoterapia versus aquellos que reciben politerapia, se pueden explicar porque existen pocas opciones de medicamentos y antianginosod asociaciones revisten riesgo. Eur J Gen Pract. Management of hyperlipidaemia after coronary revascularisation: Consejo Nacional de Seguridad Social en Salud. To determine patterns in antilipidemic drug prescriptions among a group of patients covered by the General Social Security System Sistema General de Seguridad Social in Colombia.

Of the total number of patients,